NO20030483D0 - Assosiasjoner av dalfopristin/quinupristin med cefpirom - Google Patents

Assosiasjoner av dalfopristin/quinupristin med cefpirom

Info

Publication number
NO20030483D0
NO20030483D0 NO20030483A NO20030483A NO20030483D0 NO 20030483 D0 NO20030483 D0 NO 20030483D0 NO 20030483 A NO20030483 A NO 20030483A NO 20030483 A NO20030483 A NO 20030483A NO 20030483 D0 NO20030483 D0 NO 20030483D0
Authority
NO
Norway
Prior art keywords
dalfopristine
quinupristine
cefpiroma
associations
cefpirome
Prior art date
Application number
NO20030483A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030483L (no
Inventor
Celine Feger
Philippe Moreillon
Jacques Vouillamoz
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20030483D0 publication Critical patent/NO20030483D0/no
Publication of NO20030483L publication Critical patent/NO20030483L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Thyristors (AREA)
NO20030483A 2000-08-03 2003-01-30 Assosiasjoner av dalfopristin/quinupristin med cefpirom NO20030483L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0010245A FR2812549B1 (fr) 2000-08-03 2000-08-03 Associations dalfopristine/quinupristine avec le cefpirome
PCT/FR2001/002520 WO2002011751A2 (fr) 2000-08-03 2001-08-02 Associations dalfopristine/quinupristine avec le cefpirome

Publications (2)

Publication Number Publication Date
NO20030483D0 true NO20030483D0 (no) 2003-01-30
NO20030483L NO20030483L (no) 2003-01-30

Family

ID=8853264

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030483A NO20030483L (no) 2000-08-03 2003-01-30 Assosiasjoner av dalfopristin/quinupristin med cefpirom

Country Status (29)

Country Link
US (2) US7005416B2 (ko)
EP (1) EP1313500B1 (ko)
JP (1) JP2004505926A (ko)
KR (1) KR100808715B1 (ko)
CN (1) CN1256982C (ko)
AR (1) AR033992A1 (ko)
AT (1) ATE279204T1 (ko)
AU (2) AU2001284095B2 (ko)
BR (1) BR0112897A (ko)
CA (1) CA2418023A1 (ko)
CZ (1) CZ2003290A3 (ko)
DE (1) DE60106463T2 (ko)
DK (1) DK1313500T3 (ko)
EA (1) EA007713B1 (ko)
ES (1) ES2230358T3 (ko)
FR (1) FR2812549B1 (ko)
HK (1) HK1058305A1 (ko)
HU (1) HU227455B1 (ko)
IL (1) IL154237A0 (ko)
MX (1) MXPA03000959A (ko)
NO (1) NO20030483L (ko)
NZ (1) NZ523982A (ko)
PE (1) PE20020264A1 (ko)
PL (1) PL204278B1 (ko)
PT (1) PT1313500E (ko)
SK (1) SK1202003A3 (ko)
TN (1) TNSN01116A1 (ko)
WO (1) WO2002011751A2 (ko)
ZA (1) ZA200300903B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107420042B (zh) * 2017-09-25 2023-03-31 中国地质大学（武汉） 一种基于六自由度并联机构的海底钻机自动调平系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0867676A (ja) * 1994-03-30 1996-03-12 Eisai Kagaku Kk 保護アミノチアゾリル酢酸誘導体
US5464616A (en) * 1994-08-04 1995-11-07 Synphar Laboratories, Ind. 6β-substituted penicillanic acids as beta-lactamase inhibitors
US5686441A (en) * 1995-08-04 1997-11-11 Syphar Laboratories, Inc. Penam sulfones as β-lactamase inhibitors
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
US6187746B1 (en) * 1997-12-16 2001-02-13 Rhone-Poulenc Rorer S.A. Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
US6465428B1 (en) * 1999-08-27 2002-10-15 Aventis Pharma S.A. Pharmaceutical combinations based on dalfopristine and quinupristine, and on cefepime

Also Published As

Publication number Publication date
KR20030022351A (ko) 2003-03-15
FR2812549B1 (fr) 2003-03-21
SK1202003A3 (en) 2003-07-01
US20060122103A1 (en) 2006-06-08
ES2230358T3 (es) 2005-05-01
EA007713B1 (ru) 2006-12-29
PL204278B1 (pl) 2009-12-31
BR0112897A (pt) 2003-06-10
WO2002011751A2 (fr) 2002-02-14
DE60106463D1 (de) 2004-11-18
CN1256982C (zh) 2006-05-24
PE20020264A1 (es) 2002-05-20
MXPA03000959A (es) 2003-06-09
NO20030483L (no) 2003-01-30
AU8409501A (en) 2002-02-18
ZA200300903B (en) 2003-11-10
KR100808715B1 (ko) 2008-02-29
EP1313500A2 (fr) 2003-05-28
HU227455B1 (en) 2011-06-28
US20020037890A1 (en) 2002-03-28
FR2812549A1 (fr) 2002-02-08
JP2004505926A (ja) 2004-02-26
IL154237A0 (en) 2003-07-31
CA2418023A1 (fr) 2002-02-14
CN1449290A (zh) 2003-10-15
NZ523982A (en) 2004-10-29
HUP0300682A3 (en) 2004-09-28
HK1058305A1 (en) 2004-05-14
WO2002011751A3 (fr) 2002-06-13
HUP0300682A2 (hu) 2003-08-28
CZ2003290A3 (cs) 2003-05-14
AU2001284095B2 (en) 2007-04-05
US7005416B2 (en) 2006-02-28
PT1313500E (pt) 2005-02-28
PL365075A1 (en) 2004-12-27
AR033992A1 (es) 2004-01-21
TNSN01116A1 (fr) 2005-11-10
DK1313500T3 (da) 2005-02-14
EP1313500B1 (fr) 2004-10-13
EA200300214A1 (ru) 2003-06-26
DE60106463T2 (de) 2005-10-13
ATE279204T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
ATE307608T1 (de) Kombination von doctaxel und rhumab her2 zür krebsbehandlung
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
HUP0103078A2 (hu) Készítmények és eljárások szürkehályog kezelésére
SE9900961D0 (sv) Novel compounds
SE9802208D0 (sv) Novel compounds
HK1068606A1 (en) Novel aminobenzoephenones
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
ATE395061T1 (de) Topische zusammensetzungen zur transdermalen gabe von niacin prodrugs sowie verfahren zur behandlung von hyperlipidämie
TR200102512T2 (tr) Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.
SE9902597D0 (sv) New use
SE9802209D0 (sv) Novel compounds
NO20042758L (no) Fremgangsmate for behandling av en pasient som krever analgesi.
NO20030483D0 (no) Assosiasjoner av dalfopristin/quinupristin med cefpirom
DE60236927D1 (de) Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba
SE0004827D0 (sv) Therapeutic compounds
DE60130253D1 (de) Zusammensetzungen zur verhinderung der adhäsion
EP1011672A4 (en) CONNECTIONS WITH ANALGETIC EFFECT AND COMPILATIONS THAT CONTAIN THEM
BR0003648A (pt) Composições e métodos para tratar condições alérgicas e inflamatórias com tosse
PT1150981E (pt) Composto nucleosidico terapeutico

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application